Lifecore Biomedical (LFCR) Competitors $6.74 -0.11 (-1.61%) Closing price 10/7/2025 04:00 PM EasternExtended Trading$6.76 +0.02 (+0.30%) As of 10/7/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LFCR vs. UPB, SYRE, SPRY, CRON, RAPP, PHAR, BCAX, SANA, RLAY, and PGENShould you be buying Lifecore Biomedical stock or one of its competitors? The main competitors of Lifecore Biomedical include Upstream Bio (UPB), Spyre Therapeutics (SYRE), ARS Pharmaceuticals (SPRY), Cronos Group (CRON), Rapport Therapeutics (RAPP), Pharming Group (PHAR), Bicara Therapeutics (BCAX), Sana Biotechnology (SANA), Relay Therapeutics (RLAY), and Precigen (PGEN). These companies are all part of the "pharmaceutical products" industry. Lifecore Biomedical vs. Its Competitors Upstream Bio Spyre Therapeutics ARS Pharmaceuticals Cronos Group Rapport Therapeutics Pharming Group Bicara Therapeutics Sana Biotechnology Relay Therapeutics Precigen Lifecore Biomedical (NASDAQ:LFCR) and Upstream Bio (NASDAQ:UPB) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, valuation, risk, earnings and media sentiment. Which has better earnings & valuation, LFCR or UPB? Lifecore Biomedical has higher revenue and earnings than Upstream Bio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLifecore Biomedical$128.87M1.96-$38.72M-$1.31-5.15Upstream Bio$2.37M424.68-$62.81MN/AN/A Does the media prefer LFCR or UPB? In the previous week, Upstream Bio had 3 more articles in the media than Lifecore Biomedical. MarketBeat recorded 4 mentions for Upstream Bio and 1 mentions for Lifecore Biomedical. Lifecore Biomedical's average media sentiment score of 0.67 beat Upstream Bio's score of 0.45 indicating that Lifecore Biomedical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lifecore Biomedical 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Upstream Bio 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders and institutionals hold more shares of LFCR or UPB? 83.4% of Lifecore Biomedical shares are owned by institutional investors. 32.0% of Lifecore Biomedical shares are owned by company insiders. Comparatively, 13.6% of Upstream Bio shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Do analysts rate LFCR or UPB? Lifecore Biomedical presently has a consensus target price of $8.00, suggesting a potential upside of 18.69%. Upstream Bio has a consensus target price of $56.50, suggesting a potential upside of 202.62%. Given Upstream Bio's stronger consensus rating and higher probable upside, analysts plainly believe Upstream Bio is more favorable than Lifecore Biomedical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lifecore Biomedical 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20Upstream Bio 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.60 Is LFCR or UPB more profitable? Lifecore Biomedical has a net margin of -31.70% compared to Upstream Bio's net margin of -3,836.58%. Upstream Bio's return on equity of -35.90% beat Lifecore Biomedical's return on equity.Company Net Margins Return on Equity Return on Assets Lifecore Biomedical-31.70% -846.51% -13.03% Upstream Bio -3,836.58%-35.90%-26.26% SummaryLifecore Biomedical beats Upstream Bio on 7 of the 13 factors compared between the two stocks. Get Lifecore Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for LFCR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LFCR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LFCR vs. The Competition Export to ExcelMetricLifecore BiomedicalMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$256.64M$3.35B$6.11B$10.65BDividend YieldN/A2.29%5.70%4.74%P/E Ratio-5.1521.4185.5026.85Price / Sales1.96466.25621.40135.13Price / CashN/A47.6737.7861.77Price / Book168.5010.0613.136.70Net Income-$38.72M-$52.22M$3.30B$276.44M7 Day Performance-6.00%4.25%3.92%2.48%1 Month Performance-7.54%12.50%8.39%8.79%1 Year Performance40.12%26.68%87.22%34.41% Lifecore Biomedical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LFCRLifecore Biomedical1.8324 of 5 stars$6.74-1.6%$8.00+18.7%+32.4%$256.64M$128.87M-5.15690UPBUpstream Bio1.9229 of 5 stars$18.75-1.2%$56.50+201.3%N/A$1.01B$2.37M0.0038SYRESpyre Therapeutics3.0896 of 5 stars$16.52-0.9%$54.29+228.6%-41.7%$1.00BN/A-4.8973Analyst DowngradeSPRYARS Pharmaceuticals2.7321 of 5 stars$10.13-1.4%$33.17+227.4%-24.4%$1.00B$89.15M-20.6790CRONCronos Group1.4784 of 5 stars$2.62+2.5%N/A+19.1%$997.44M$130.28M52.10450RAPPRapport Therapeutics3.1938 of 5 stars$27.15-2.1%$35.33+30.1%+25.7%$990.90MN/A-10.86N/APHARPharming Group2.3216 of 5 stars$14.45-6.1%$30.00+107.7%+74.6%$989.70M$297.20M-111.12280Short Interest ↑High Trading VolumeBCAXBicara Therapeutics2.3649 of 5 stars$17.84-1.1%$32.25+80.8%-25.7%$977.77MN/A-5.6532SANASana Biotechnology3.2192 of 5 stars$4.08-2.0%$7.50+84.0%-2.1%$971.45MN/A-3.85380Positive NewsRLAYRelay Therapeutics2.8256 of 5 stars$5.58-0.3%$16.50+195.9%-8.0%$968.09M$8.36M-2.88330Positive NewsPGENPrecigen4.5512 of 5 stars$3.22+2.4%$8.25+156.6%+289.4%$958.57M$3.92M-7.66190Gap Up Related Companies and Tools Related Companies Upstream Bio Competitors Spyre Therapeutics Competitors ARS Pharmaceuticals Competitors Cronos Group Competitors Rapport Therapeutics Competitors Pharming Group Competitors Bicara Therapeutics Competitors Sana Biotechnology Competitors Relay Therapeutics Competitors Precigen Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LFCR) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredU.S. Government Blocked NVIDIA’s Buyout… Here’s WhyThe U.S. government doesn't normally block billion-dollar tech deals. But when NVIDIA tried to acquire this...Behind the Markets | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored"I'm risking my reputation on this"My prediction: Q4 2025 won't just be another seasonal crypto pump. It will be the quarter that sparks a crypto...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lifecore Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lifecore Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
